Our data suggest that autologous blood transfusion via CS results in fewer perioperative complications and faster recovery following OPCAB procedures as compared to ABT.
Keyphrases
- coronary artery bypass
- cell therapy
- percutaneous coronary intervention
- bone marrow
- risk factors
- platelet rich plasma
- single cell
- cardiac surgery
- magnetic resonance
- electronic health record
- patients undergoing
- stem cells
- minimally invasive
- acute coronary syndrome
- big data
- mesenchymal stem cells
- contrast enhanced
- network analysis
- machine learning
- artificial intelligence